Sponsor of New Calif. Stem Cell Law to Address BIO VentureForum 2002

  • Contact: Carrie Housman, BIO, (202) 345-3677, (415) 537-6208
    Ashley Myler, SheaHedges Group, (703) 362-4204
  • Recommend
  • Tweet
  • Print
  • Email

SAN FRANCISCO (October 1, 2002) – California State Senator Deborah Ortiz (D-
Sacramento) will be available for media interviews to discuss the new state law endorsing embryonic stem cell research, including nuclear transplantation, tomorrow during the BIO VentureForum 2002 conference at the Palace Hotel.

California Gov. Gray Davis signed Senate Bill 253 in September, making California the first state to endorse stem cell research. Stem cell research is a promising area that could be a new pathway to finding cures for intractable diseases. The law, sponsored by Ortiz, creates a review process for stem cell research that allows the state government to fund this emerging field of biomedical research. The law will also enable scientists to start new cell lines for laboratory research in California.


WHO: State Senator Deborah Ortiz (D-Sacramento)
WHAT: Remarks and media availability
WHERE: BIO VentureForum 2002, Ralston Ballroom, Palace Hotel, Two New Montgomery Street, San Francisco
WHEN: Wednesday, October 2, 12:15 p.m. Media availability immediately following the closing plenary luncheon scheduled to conclude at 2:00 p.m.

Media representatives must be registered for the conference to attend the plenary luncheon and to meet with Sen. Ortiz. Onsite press registration is complimentary for credentialed members of the news media. Photo identification is required.

BIO represents more than 1,000 biotechnology companies, academic institutions, state biotechnology centers and related organizations in all 50 U.S. states and 33 other nations. BIO members are involved in the research and development of health-care, agricultural, industrial and environmental biotechnology products.

# # #

About BIO
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.